BioMarin (BMRN) Secured 20% U.S. Royalties on Yuviwel. Is Monetizing a Rival Better than Blocking It?
finance.yahoo.com
04.09.2026 18:26
46 views
Related stories
China’s villages pay the price for Beijing’s AI ambitions
ft.com · 20.10
Trump envoys to hold fresh Ukraine talks as energy crunch looms over midterms
ft.com · 20.10
'I'm fed up of swiping': Why singles now want to meet IRL
bbc.co.uk · 20.10
Anthropic and Nscale in talks for second multibillion-dollar deal
ft.com · 20.10
Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.
marketwatch.com · 19.10
Credit markets have entered uncharted territory as the riskiest junk bonds send a warning to investors
marketwatch.com · 19.10